TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹1,820 Cr | ₹2,089 Cr | ₹1,679 Cr | ₹1,674 Cr | ₹2,067 Cr |
What is the latest Trade Payables ratio of TORRENT PHARMACEUTICALS ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹1,820 Cr |
| Mar2024 | ₹2,089 Cr |
| Mar2023 | ₹1,679 Cr |
| Mar2022 | ₹1,674 Cr |
| Mar2021 | ₹2,067 Cr |
How is Trade Payables of TORRENT PHARMACEUTICALS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,820 Cr | -12.89 | |
| Mar2024 | ₹2,089 Cr | 24.45 | |
| Mar2023 | ₹1,679 Cr | 0.26 | |
| Mar2022 | ₹1,674 Cr | -18.98 | |
| Mar2021 | ₹2,067 Cr | - | |
Compare Trade Payables of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹134,102.8 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,806.8 Cr | 0.3% | 2.4% | -22.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.4% |
4.5% |
18.3% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses